Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Gyeonggi-do, Republic of Korea.
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Eur J Endocrinol. 2019 Nov;181(5):489-498. doi: 10.1530/EJE-19-0500.
Obesity and type 2 diabetes are becoming increasingly prevalent worldwide and are both associated with the increased incidence of kidney and bladder cancers. However, previous reports have provided conflicting results. We investigated the impact of body mass index (BMI) and diabetes on the incidence of both cancers in the general population.
Using nationally representative data from the Korean National Health Insurance System, 9,777,133 subjects without any malignancy who underwent health examinations in 2009 were followed to the end of 2017.
After a median follow-up period of 8.32 years, 12,544 incidents of kidney cancer and 15,137 incidents of bladder cancer were identified. The hazard ratio (HR) for kidney cancer was the lowest in people with a BMI <18.5 kg/m2 (HR: 0.82, 95% confidence interval (CI): 0.72-0.94) and the highest in those with a BMI ≥30 kg/m2 (HR: 1.71, 95% CI: 1.57-1.87) compared to a reference BMI group (18.5-23 kg/m2). In subjects with diabetes, obesity was associated with increased risk of kidney cancer, although the HRs were lower than observed in those without diabetes. Otherwise, there was a reduction in risk of bladder cancer with obesity in men and the HR for bladder cancer was not affected by BMI increase in women. There was a strongly positive association between diabetes and bladder cancer in the total study population.
Obesity was a strong risk factors for kidney cancer, whereas the association between obesity and bladder cancer differed by gender. The subjects with diabetes had a higher risk for both cancers than those without diabetes.
肥胖和 2 型糖尿病在全球范围内日益流行,且均与肾脏和膀胱癌发病率的增加有关。然而,先前的报告结果存在差异。本研究旨在调查身体质量指数(BMI)和糖尿病对普通人群中这两种癌症发病的影响。
利用韩国国家健康保险系统的全国代表性数据,对 2009 年接受健康检查且无任何恶性肿瘤的 9777133 名受试者进行了随访,随访至 2017 年底。
中位随访 8.32 年后,共发现 12544 例肾癌和 15137 例膀胱癌。与参考 BMI 组(18.5-23kg/m2)相比,BMI<18.5kg/m2 者肾癌发病风险最低(HR:0.82,95%CI:0.72-0.94),BMI≥30kg/m2 者最高(HR:1.71,95%CI:1.57-1.87)。在合并糖尿病的患者中,肥胖与肾癌风险增加相关,不过 HR 低于无糖尿病患者。相反,男性肥胖与膀胱癌风险降低相关,而女性 BMI 增加与膀胱癌风险无关。在总研究人群中,糖尿病与膀胱癌之间存在强正相关关系。
肥胖是肾癌的一个强烈危险因素,而肥胖与膀胱癌之间的关系因性别而异。与无糖尿病者相比,合并糖尿病者发生这两种癌症的风险更高。